Connection
Jennifer Goldman to Respiratory Insufficiency
This is a "connection" page, showing publications Jennifer Goldman has written about Respiratory Insufficiency.
|
|
Connection Strength |
|
 |
|
 |
|
3.082 |
|
|
|
-
Miller J, Khan H, Mino-Kenudson M, Taylor M, Shih A, Goldman J. Definition and Clinical Evaluation for Trimethoprim-Sulfamethoxazole Severe Acute Respiratory Failure. Crit Care Med. 2023 12 01; 51(12):e264-e268.
Score: 0.877
-
Goldman JL, Miller JO, Miller N, Eveleigh R, Gibson A, Phillips EJ, Pastinen T. HLA-B*07:02 and HLA-C*07:02 are associated with trimethoprim-sulfamethoxazole respiratory failure. Pharmacogenomics J. 2022 03; 22(2):124-129.
Score: 0.796
-
Miller JO, Shih AR, Mino-Kenudson M, Taylor MS, Goldman JL. Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults. Am J Respir Crit Care Med. 2021 04 01; 203(7):918-921.
Score: 0.749
-
Miller JO, Taylor J, Goldman JL. Severe Acute Respiratory Failure in Healthy Adolescents Exposed to Trimethoprim-Sulfamethoxazole. Pediatrics. 2019 06; 143(6).
Score: 0.659